|
|
Advertisement
|
|
Registration Is Open for the 2026 NEXT Summit
Novel Explorations in Combination Therapies
Be among the first to secure your spot and take advantage of early bird rates for the 2026 NEXT Summit: Novel Explorations in Combination Therapies, taking place 28–29 May 2026, at the Gleacher Center in Chicago!
Led by SIO and developed in collaboration with the Society for Immunotherapy of Cancer (SITC) and the American Association for the Study of Liver Diseases (AASLD), the NEXT Summit is a two-day, in-person program designed to advance clinically integrated, case-based education in interventional oncology.
The 2026 program moves beyond incremental updates to focus on how emerging therapies are being applied in real-world practice. Through expert-led lectures and case-based discussions, attendees will examine updates in pivotal clinical trials data since 2025, explore novel therapeutic applications including intratumoral therapies, and evaluate next-generation combination approaches shaping patient care and advancing the future role of interventional oncology.
Designed for a multidisciplinary audience, the NEXT Summit brings together interventional radiologists, medical oncologists, hepatologists, surgeons, radiation oncologists, and other multidisciplinary partners to learn, collaborate, and make better-informed clinical decisions.
The future of interventional oncology starts this summer. Are you ready for what's NEXT?
Learn More and Register
|
Advertisement
|
|
Thank You for Joining Us in Savannah
Thank you for attending the SIO 2026 Annual Scientific Meeting in Savannah! We hope you gained valuable insights and made lasting connections.
Share Your Feedback
Your feedback is very important to us. We ask that you consider your experience in Savannah and share your thoughts in this short survey. Please complete the survey by 31 March.
Take Survey
Earning CME
You must complete this CME evaluation in order to claim credit for your participation. Additional CME information is available in the mobile app. All evaluations must be completed by 31 March. By attending the event, you are eligible to earn up to 23.75 AMA PRA Category 1 CME credits.
The program is jointly provided by Creighton University Health Sciences Continuing Education and the Society of Interventional Oncology.
Complete CME Evaluation
Accessing Session Recordings
Session recordings from the Annual Scientific Meeting will be available in the coming weeks. We will notify all attendees as soon as access is available in the SIO Learning Center. Attendees receive complimentary access to all recordings, while non‑attendees may purchase access.
|
|
Join SIO in 2026
There's no better time to invest in your future in interventional oncology. By becoming an SIO member, you join a global community dedicated to advancing the IO field and supporting your professional growth.
As an SIO member, you'll gain immediate access to exclusive education, cutting-edge research, member-only resources, event discounts, opportunities to earn CME credit, and timely insights that keep you at the forefront of the specialty.
Already a member? Make sure your benefits continue into 2026 by renewing today and staying connected to the resources and community that help drive your career forward.
Join SIO Today
|
Advertisement
|
Promoted by Medtronic
Outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation System from the OPuS One trial were recently published in the November edition of the Journal of Vascular and Interventional Radiology (JVIR). Learn more about the largest prospective study in radiofrequency ablation for bone metastases. Learn More
|
|
IO Insights
The Society of Interventional Oncology
2001 K Street NW, 3rd Floor North | Washington, DC 20006 USA
202-367-1164 | Contact Us
www.sio-central.org
|
|
|
|
|
|